ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 23 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $51,000 | -32.0% | 23,221 | +3.4% | 0.01% | -44.4% |
Q3 2021 | $75,000 | +21.0% | 22,457 | -2.6% | 0.01% | 0.0% |
Q2 2021 | $62,000 | 0.0% | 23,058 | -20.6% | 0.01% | -35.7% |
Q1 2021 | $62,000 | +72.2% | 29,031 | +101.0% | 0.01% | +27.3% |
Q4 2020 | $36,000 | – | 14,442 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 1,349,953 | $8,046,000 | 2.52% |
Novo Holdings A/S | 2,181,843 | $13,004,000 | 2.23% |
Sofinnova Investments, Inc. | 1,180,178 | $7,034,000 | 0.64% |
TPG Group Holdings (SBS) Advisors, Inc. | 2,041,496 | $12,168,000 | 0.09% |
Eventide Asset Management | 392,513 | $2,288,000 | 0.08% |
Blackstone Inc. | 1,623,405 | $9,675,000 | 0.06% |
Granahan Investment Management | 141,012 | $840,000 | 0.05% |
Janney Montgomery Scott LLC | 46,861 | $279,000 | 0.00% |
BANK OF MONTREAL /CAN/ | 5,921 | $35,000 | 0.00% |
BlackRock Inc. | 15,755 | $94,000 | 0.00% |